RecruitingNot ApplicableNCT06420115
Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects?
AOP2780 - Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects?
Sponsor
University Hospital Padova
Enrollment
580 participants
Start Date
Jun 1, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Differences in terms of diagnostic capability and side effects related to the needle caliber used for prostate biopsy sampling in patients with suspected prostate cancer
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Clinical suspicion of prostate cancer (presence of elevated prostatic specific antigen and/or suspicious digital rectal examination);
- Presence of at least one suspicious prostate lesion on MRI (Prostate Imaging-Reporting and Data System ≥ 3) according to the Prostate Imaging-Reporting and Data System v2.1 performed before Magnetic Resonance Imaging/transrectal ultrasound fusion biopsy.
Exclusion Criteria2
- Patients under active surveillance or with a previous diagnosis of prostate neoplasia prior to biopsy.
- Previous radiotherapy to the prostate for neoplasia.
Interventions
DEVICEdifferent needle size for prostate biopsy
MRI Fusion Transperineal Prostate Biopsy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06420115
Related Trials
Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer
NCT071442281 location
INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis
NCT073986901 location
Comparison of TB+PB and TB+6SB for Prostate Cancer Diagnosis
NCT074608431 location
Evolution of Lesions in Repeated Biparametric Prostate Magnetic Resonance Imaging
NCT073695701 location
PSMA PET for Surveillance After Focal Therapy
NCT071159141 location